155 related articles for article (PubMed ID: 33644623)
1. Flash CGM Is Associated With Reduced Diabetes Events and Hospitalizations in Insulin-Treated Type 2 Diabetes.
Bergenstal RM; Kerr MSD; Roberts GJ; Souto D; Nabutovsky Y; Hirsch IB
J Endocr Soc; 2021 Apr; 5(4):bvab013. PubMed ID: 33644623
[TBL] [Abstract][Full Text] [Related]
2. Flash CGM associated with event reduction in nonintensive diabetes therapy.
Miller E; Kerr MSD; Roberts GJ; Nabutovsky Y; Wright E
Am J Manag Care; 2021 Nov; 27(11):e372-e377. PubMed ID: 34784145
[TBL] [Abstract][Full Text] [Related]
3. Reduced Rate of Hospitalizations for Acute Diabetes Events Before and After FreeStyle Libre
Riveline JP; Levrat-Guillen F; Detournay B; Vicaut E; De Pouvourville G; Emery C; Guerci B
Diabetes Technol Ther; 2024 Jul; ():. PubMed ID: 38885325
[No Abstract] [Full Text] [Related]
4. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
Matsuda E; Brennan P
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
[TBL] [Abstract][Full Text] [Related]
5. Budget Impact of the Flash Continuous Glucose Monitoring System in Medicaid Diabetes Beneficiaries Treated with Intensive Insulin Therapy.
Frank JR; Blissett D; Hellmund R; Virdi N
Diabetes Technol Ther; 2021 Sep; 23(S3):S36-S44. PubMed ID: 34546079
[No Abstract] [Full Text] [Related]
6. Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France.
Guerci B; Roussel R; Levrat-Guillen F; Detournay B; Vicaut E; De Pouvourville G; Emery C; Riveline JP
Diabetes Technol Ther; 2023 Jan; 25(1):20-30. PubMed ID: 36094418
[No Abstract] [Full Text] [Related]
7. Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy.
Wright EE; Kerr MSD; Reyes IJ; Nabutovsky Y; Miller E
Diabetes Spectr; 2021 May; 34(2):184-189. PubMed ID: 34149259
[TBL] [Abstract][Full Text] [Related]
8. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
[TBL] [Abstract][Full Text] [Related]
9. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
Rodbard D
Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
[TBL] [Abstract][Full Text] [Related]
10. Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study.
Roussel R; Riveline JP; Vicaut E; de Pouvourville G; Detournay B; Emery C; Levrat-Guillen F; Guerci B
Diabetes Care; 2021 Jun; 44(6):1368-1376. PubMed ID: 33879536
[TBL] [Abstract][Full Text] [Related]
11. Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.
Majithia AR; Wiltschko AB; Zheng H; Walford GA; Nathan DM
J Diabetes Sci Technol; 2018 Jan; 12(1):76-82. PubMed ID: 28868899
[TBL] [Abstract][Full Text] [Related]
12. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
[TBL] [Abstract][Full Text] [Related]
13. Practical Considerations for Initiating and Utilizing Flash Continuous Glucose Monitoring in Clinical Practice.
Wysham CH; Kruger DF
J Endocr Soc; 2021 Sep; 5(9):bvab064. PubMed ID: 34291180
[TBL] [Abstract][Full Text] [Related]
14. Remote Pharmacist-Assisted Flash Continuous Glucose Monitoring Improves Glycemic Outcomes in Patients With Poorly Controlled Diabetes: A Retrospective Case Series.
Siemens R
Clin Diabetes; 2022; 40(2):211-221. PubMed ID: 35669305
[TBL] [Abstract][Full Text] [Related]
15. High incidence of hypoglycemia in stable insulin-treated type 2 diabetes mellitus: continuous glucose monitoring vs. self-monitored blood glucose. Observational prospective study.
Pazos-Couselo M; García-López JM; González-Rodríguez M; Gude F; Mayán-Santos JM; Rodríguez-Segade S; Rodríguez-García J; Casanueva F
Can J Diabetes; 2015 Oct; 39(5):428-33. PubMed ID: 26254702
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Winn A; Zarei P; O'Grady M; Huang ES
Diabetes Care; 2018 Jun; 41(6):1227-1234. PubMed ID: 29650803
[TBL] [Abstract][Full Text] [Related]
17. The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring.
Bronstone A; Graham C
J Diabetes Sci Technol; 2016 Jul; 10(4):905-13. PubMed ID: 26880392
[TBL] [Abstract][Full Text] [Related]
18. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P
Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746
[TBL] [Abstract][Full Text] [Related]
19. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719
[TBL] [Abstract][Full Text] [Related]
20. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
